{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T15:06:04Z","timestamp":1772463964068,"version":"3.50.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[1999,6]]},"DOI":"10.1016\/s0014-2999(99)00330-1","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T17:48:33Z","timestamp":1027619313000},"page":"31-40","source":"Crossref","is-referenced-by-count":280,"title":["Antidepressants for the new millennium"],"prefix":"10.1016","volume":"375","author":[{"given":"Phil","family":"Skolnick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0014-2999(99)00330-1_BIB1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-6147(99)01309-7","article-title":"Neurotrophins and depression","volume":"20","author":"Altar","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.ne.16.030193.000313","article-title":"Transsynaptic control of gene expression","volume":"16","author":"Armstrong","year":"1993","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/archpsyc.1994.03950030084009","article-title":"Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors","volume":"51","author":"Artigas","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB4","doi-asserted-by":"crossref","first-page":"15730","DOI":"10.1073\/pnas.95.26.15730","article-title":"Modulation of N-methyl-d-aspartate receptor function by glycine transport","volume":"95","author":"Bergeron","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1176\/ajp.154.1.37","article-title":"Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial","volume":"154","author":"Berman","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB6","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0028-3908(96)00122-0","article-title":"The antidepressant metapramine is a low-affinity antagonist at N-methyl-d-aspartic acid receptors","volume":"12","author":"Boireau","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00176837","article-title":"Is the forced swim test a suitable model for revealing antidepressant activity?","volume":"94","author":"Borsini","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF02761776","article-title":"Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain","volume":"10","author":"Boyer","year":"1998","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB9","doi-asserted-by":"crossref","first-page":"7953","DOI":"10.1523\/JNEUROSCI.18-19-07953.1998","article-title":"Brain-derived neurotrophic factor and basic fibroblast growth factor downregulate NMDA receptor function in cerebellar granule cells","volume":"18","author":"Brandoli","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB10","unstructured":"Cappiello, A., Berman, R.M., Anand, A., Charney, D.S., Krystal, J.H., 1998. NMDA receptor function in major depression. The Glutamate Cascade: Common Pathways of Central Nervous System Diseases. p. 44 (abstract)."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB11","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/jps.2600841016","article-title":"1-Aminocyclopropanecarboxylic acid: mouse to man interspecies pharmacokinetic comparisons and allometric relationships","volume":"84","author":"Cherkofsky","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0896-6273(88)90162-6","article-title":"Glutamate neurotoxicity and diseases of the nervous system","volume":"1","author":"Choi","year":"1988","journal-title":"Neuron"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0006-8993(89)90789-0","article-title":"Ethanol inhibits NMDA-induced increases in free intracellular Ca2+ in dissociated brain cells","volume":"499","author":"Dildy","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archpsyc.1997.01830190015002","article-title":"A molecular and cellular theory of depression","volume":"54","author":"Duman","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB15","doi-asserted-by":"crossref","unstructured":"Duman, R.S., Nibuya, M., Vaidya, V.A., 1997. A role for CREB in antidepressant action. In: Skolnick, P. (Ed.), Antidepressants: New Pharmacological Strategies. Humana Press, Totowa, pp. 173\u2013194.","DOI":"10.1007\/978-1-59259-474-0_10"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF02316874","article-title":"A rapid method for evaluating the behavioral effects of dissociative anesthetics in mice","volume":"105","author":"Evoniuk","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/16269","article-title":"The AMPA receptor interactions with and signals through the protein tyrosine kinase Lyn","volume":"397","author":"Hayashi","year":"1999","journal-title":"Nature"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/(SICI)1097-4547(19981115)54:4<444::AID-JNR2>3.0.CO;2-3","article-title":"Synaptic coexistence of AMPA and NMDA receptors in the rat hippocampus: a postembedding immunogold study","volume":"54","author":"He","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB19","first-page":"23","article-title":"Clinical effects of the neurotrophic selective cAMP phosphodiesterase inhibitor rolipram in depressed patients: global evaluation of the preliminary reports","volume":"38","author":"Horowski","year":"1985","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB20","doi-asserted-by":"crossref","unstructured":"Huang, N.-Y., Layer, R.T., Skolnick, P., 1997. Is an adaptation of NMDA receptors an obligatory step in antidepressant action? In: Skolnick, P. (Ed.), Antidepressants: New Pharmacological Strategies. Humana Press, Totowa, pp. 125\u2013143.","DOI":"10.1007\/978-1-59259-474-0_7"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF02800499","article-title":"Chronic antidepressant treatments increase Cytochrome b mRNA levels in mouse cerebral cortex","volume":"9","author":"Huang","year":"1997","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1359-6446(97)01000-3","article-title":"PDE 4 inhibitors: the use of molecular cloning in the design and development of novel drugs","volume":"2","author":"Hughes","year":"1997","journal-title":"Drug Discovery Today"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB23","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1113\/jphysiol.1996.sp021807","article-title":"A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in cultured cortical neurones","volume":"497","author":"Kew","year":"1996","journal-title":"J. Physiol."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0006-3223(96)00047-9","article-title":"Psychotogenicity and N-methyl-d-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy","volume":"41","author":"Kornhuber","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0169-328X(96)00072-1","article-title":"Regulation of alternative splicing of NMDAR1 in the kindling model","volume":"41","author":"Kraus","year":"1996","journal-title":"Mol. Brain Res."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic doses of the noncompetitive NMDA antagonist, ketamine in humans: psychotomimetic, perceptual, cognitive and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0922-4106(94)90058-2","article-title":"Ligand affinities at recombinant N-methyl-d-aspartate receptors depend on subunit composition","volume":"268","author":"Laurie","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0091-3057(95)00155-P","article-title":"Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL 82.0715)","volume":"52","author":"Layer","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB30","doi-asserted-by":"crossref","unstructured":"Layer, R.T., Popik, P., Nowak, G., Paul, I.A., Trullas, R., Skolnick, P., 1998. A unified theory of antidepressant action: evidence for adaptation of the N-methyl-d-aspartate (NMDA) receptor following chronic antidepressant treatments. In: Ce\u00f1a, V., Soria, B. (Eds.), Ion Channel Pharmacology. Oxford University Press, Oxford, pp. 438\u2013456.","DOI":"10.1093\/oso\/9780198523604.003.0020"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB31","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1354393","article-title":"Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction","volume":"257","author":"Liang","year":"1992","journal-title":"Science"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0014-2999(94)90120-1","article-title":"1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury","volume":"261","author":"Long","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3940(91)90258-U","article-title":"The N-methyl-d-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions","volume":"128","author":"Loscher","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB34","first-page":"337","article-title":"The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test","volume":"44","author":"Maj","year":"1992","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0924-977X(92)90034-6","article-title":"The effects of MK-801 and antidepressant drugs in the forced swimming test in rats","volume":"2","author":"Maj","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB36","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1176\/ajp.154.4.579","article-title":"Efficacy of papaverine addition for treatment-refractory major depression","volume":"154","author":"Malison","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB37","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1523\/JNEUROSCI.15-12-07929.1995","article-title":"BDNF promotes the survival and sprouting of serotonergic axons in the rat brain","volume":"15","author":"Mamounas","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB38","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1046\/j.1471-4159.1996.67051965.x","article-title":"Effects of subchronic clozapine and haloperidol on strial glutamatergic synapses","volume":"67","author":"Meshul","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB39","first-page":"184","article-title":"Regulation of cyclic AMP inducible genes by CREB","volume":"13","author":"Montminy","year":"1990","journal-title":"T.I.N.S."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0773.1993.tb01351.x","article-title":"Potential antidepressive properties of amantadine, memantine and bifemelane","volume":"72","author":"Moryl","year":"1993","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0169-328X(95)00264-S","article-title":"Repeated electroconvulsive shock induces GluR1 mRNA but not NMDAR1A-G mRNA in the rat hippocampus","volume":"35","author":"Naylor","year":"1996","journal-title":"Mol. Brain Res."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB42","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of BDNF and trkB mRNA following chronic electroconvulsive seizure and antidepressant drug treatments","volume":"15","author":"Nibuya","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB43","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1523\/JNEUROSCI.16-07-02365.1996","article-title":"Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus","volume":"16","author":"Nibuya","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB44","first-page":"1380","article-title":"Adaptive changes in the N-methyl-d-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid","volume":"265","author":"Nowak","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0014-2999(95)00585-4","article-title":"Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment","volume":"295","author":"Nowak","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB46","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0006-3223(98)00011-0","article-title":"The prevalence of depressive disorders in the United Kingdom","volume":"45","author":"Ohayon","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB47","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0924-977X(93)90130-E","article-title":"Similar effects of chronic treatment with imipramine and the NMDA antagonists CGP 37849 and MK-801 in a chronic mild stress model of depression in rats","volume":"3","author":"Papp","year":"1993","journal-title":"Eur. J. Neuropsychopharmacol."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(94)90516-9","article-title":"Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression","volume":"263","author":"Papp","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-2999(96)00675-9","article-title":"Antidepressant-like effects of 1-aminocyclopropanecarboxylic acid and d-cycloserine in an animal model of depression","volume":"316","author":"Papp","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0028-3908(98)00161-0","article-title":"Memantine is a clinically well tolerated NMDA receptor antagonist \u2014 a review of preclinical data","volume":"38","author":"Parsons","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00004850-199409000-00003","article-title":"Lack of amnestic, psychotomimetic or impairing effect on psychomotor performance of eliprodil, a new NMDA antagonist","volume":"9","author":"Patat","year":"1994","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB52","first-page":"95","article-title":"Adaptation of the N-methyl-d-aspartate receptor complex following chronic antidepressant treatments","volume":"269","author":"Paul","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB53","unstructured":"Porsolt, R.D., Lenegre, A., 1992. Behavioural models of depression. In: Elliott, J.M., Heal, D.J., Marsden, C.A. (Eds.), Experimental Approaches to Anxiety and Depression. Wiley, London, pp. 73\u201385."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0028-3908(96)00157-8","article-title":"Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA antagonist","volume":"36","author":"Przegalinski","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB55","first-page":"223","article-title":"Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds","volume":"42","author":"Rogawski","year":"1990","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB56","unstructured":"Romano, C., Williams, K., 1994. Modulation of NMDA receptors by polyamines. In: Carter, C. (Ed.), The Neuropharmacology of Polyamines. Academic Press, London, pp. 81\u2013106."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0006-8993(95)00459-4","article-title":"Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant","volume":"687","author":"Rossby","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB58","doi-asserted-by":"crossref","unstructured":"Rossby, S.P., Sulser, F., 1997. Antidepressants: beyond the synapse. In: Skolnick, P. (Ed.), Antidepressants: New Pharmacological Strategies. Humana Press, Totowa, pp. 195\u2013212.","DOI":"10.1007\/978-1-59259-474-0_11"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB59","unstructured":"Scatton, B., Avenet, P., Benavides, J., Carter, C., Duverger, D., Oblin, A., Perrault, G., Sanger, D., Schoemaker, H., 1994. Neuroprotective potential of the polyamine site-directed NMDA receptor antagonists \u2014 ifenprodil and eliprodil. In: Palfreyman, M.G., Reynolds, I.J., Skolnick, P. (Eds.), Direct and Allosteric Control of Glutamate Receptors. CRC Press, Boca Raton, pp. 139\u2013154."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB60","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/BF02245261","article-title":"Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-d-aspartate receptor complex","volume":"107","author":"Skolnick","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB61","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1046\/j.1471-4159.1998.71041554.x","article-title":"Transcriptional and translational regulation of phosphodiesterase Type IV isozymes in rat brain by electroconvulsive and antidepressant drug treatment","volume":"71","author":"Suda","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB62","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0920-1211(93)90031-2","article-title":"The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy","volume":"16","author":"Sveinbjornsdottir","year":"1993","journal-title":"Epilepsy Res."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB63","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s007020050101","article-title":"Brain-derived neurotrophic factor (BDNF) protects cultured rat cerebellar granule neurons against glucose deprivation-induced apoptosis","volume":"105","author":"Tong","year":"1998","journal-title":"J. Neural Transm."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB64","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0955-0674(96)80067-6","article-title":"Regulation of transcription by MAP kinase cascades","volume":"8","author":"Treisman","year":"1996","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists at the NMDA receptor complex exhibit antidepressant actions","volume":"185","author":"Trullas","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB66","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(91)90894-V","article-title":"1-Aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models","volume":"203","author":"Trullas","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB67","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/00001756-199309150-00015","article-title":"Preferential co-assembly of recombinant NMDA receptors composed of three different subunits","volume":"4","author":"Wafford","year":"1993","journal-title":"NeuroReport"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB68","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0006-8993(97)00159-5","article-title":"Single doses of MK-801, a non-competitive antagonist of NMDA receptors, increase the number of 5-HT1A serotonin receptors in the rat brain","volume":"756","author":"Wedzony","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB69","first-page":"851","article-title":"Ifenprodil discriminates subtypes of the N-methyl-d-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors","volume":"44","author":"Williams","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S0014-2999(99)00330-1_BIB70","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s002130050456","article-title":"Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation","volume":"134","author":"Willner","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB71","doi-asserted-by":"crossref","unstructured":"Willner, P., Papp, M., 1997. Animal models to detect antidepressants: are new strategies necessary to detect new agents? In: Skolnick, P. (Ed.), Antidepressants: New Pharmacological Strategies. Humana Press, Totowa, pp. 213\u2013234.","DOI":"10.1385\/0-89603-469-0:213"},{"key":"10.1016\/S0014-2999(99)00330-1_BIB72","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00001756-199601310-00005","article-title":"1-Aminocyclopropanecarboxylic acid reduces NMDA-induced hippocampal neurodegeneration in vivo","volume":"7","author":"Zapata","year":"1996","journal-title":"NeuroReport"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299999003301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299999003301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T23:25:26Z","timestamp":1704065126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299999003301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6]]},"references-count":72,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[1999,6]]}},"alternative-id":["S0014299999003301"],"URL":"https:\/\/doi.org\/10.1016\/s0014-2999(99)00330-1","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[1999,6]]}}}